Vanderbilt Researchers Cleared to Start Alzheimer's Drug Human Trials
NASHVILLE, Tenn. - Scientists at Vanderbilt University will soon start testing a new Alzheimer's drug on human patients.
The FDA authorized researchers to test the drug, which they say has the potential to improve cognitive functions with fewer side effects.
The first step is to test the effects on healthy young men who do not have Alzheimer's.
The process of getting from there to when the drug could be on the market could take up to 15 years.